Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Vidofludimus Calcium

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunic To Unveil More Phase 2 Vidofludimus Calcium Data
    Immunic To Unveil More Phase 2 Vidofludimus Calcium Data

    04 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-to-present-additional-phase-2-calliper-trial-data-for-vidofludimus-calcium-at-the-actrims-forum-2026-reinforcing-its-potential-in-progressive-multiple-sclerosis-302678716.html

    PR NEWSWIRE
    04 Feb 2026
    Share Share
    Immunic Highlights 2025 Accomplishments And Upcoming Milestones
    Immunic Highlights 2025 Accomplishments And Upcoming Milestones

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-highlights-2025-accomplishments-and-upcoming-milestones-302653601.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Immunic Reports Q3 2025 Financials & Corporate Update
    Immunic Reports Q3 2025 Financials & Corporate Update

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-inc-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302614351.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    Immunic Showcases Vidofludimus Calcium Data At Ectrims Congress
    Immunic Showcases Vidofludimus Calcium Data At Ectrims Congress

    25 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-presented-key-vidofludimus-calcium-data-at-the-41st-congress-of-ectrims-highlighting-its-potential-in-multiple-sclerosis-302566933.html

    PR NEWSWIRE
    25 Sep 2025
    Share Share
    Immunic Gets US Patent Notice for Vidofludimus Calcium Dose
    Immunic Gets US Patent Notice for Vidofludimus Calcium Dose

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for-united-states-patent-protecting-vidofludimus-calciums-dose-strengths-in-progressive-multiple-sclerosis-302550163.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    Immunic Reports Positive Long-Term Data From Vidofludimus Trial
    Immunic Reports Positive Long-Term Data From Vidofludimus Trial

    24 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunic-reports-new-positive-long-term-open-label-extension-data-from-phase-2-emphasis-trial-of-vidofludimus-calcium-in-relapsing-remitting-multiple-sclerosis-302489105.html

    PR NEWSWIRE
    24 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.